Avri Havron
Directeur/Membre du Conseil chez Active P Ltd.
Fortune : 260 333 $ au 30/04/2024
Postes actifs de Avri Havron
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Directeur/Membre du Conseil | 03/03/2010 | - |
Historique de carrière de Avri Havron
Anciens postes connus de Avri Havron
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Modigen Ltd. | Corporate Officer/Principal | - | - |
AngioB Ltd.
 AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Israël | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Health Technology |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
| Modigen Ltd. |
- Bourse
- Insiders
- Avri Havron
- Expérience